Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 8, 2026 · Multiple disclosures including leadership change and material agreement
STANDARD BIOTOOLS INC.
54
Leadership change
Jun 8, 2026
| Item 1.01 | Entered a material definitive agreement |
| Item 3.02 | Item 3.02 |
| Item 5.01 | Item 5.01 |
| Item 5.02 | Director or executive officer departure or appointment |
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 9.01 | Financial statements and exhibits |
STANDARD BIOTOOLS INC. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
1 Standard BioTools and Treeline Biosciences Announce Merger Agreement Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates Company to be led by Treeline CEO and co-founder Josh Bilenker, MD, and experienced team of proven drug developers Treeline’s pipeline includes three Phase 1 programs with multiple anticipated clinical data readouts beginning in 2027 Well capitalized with over $900 mill…
This filing reports Item 1.01 (entered a material definitive agreement); Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
STANDARD BIOTOOLS INC. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
